Shantanu Banerji - Concepedia

Author

Shantanu Banerji

Also Known As

Ahmet Leylek, Banerji, Shantanu, S Banerji, S. Banerji, Shantanu Banerji, Shantanu O. Banerji, Shantanu Otto Banerji, Subhangi Banerji

Publications

6.6K

Citations

H-Index

Concepts

All Affiliations

University of Manitoba CancerCare Manitoba Research Institute in Oncology and Hematology Princess Margaret Cancer Centre University of Toronto

About

Shantanu Banerji is an author at University of Manitoba specializing in medicine, tumor biology, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	5.8K
2	Engineering	5	5	4.7K
3	Cell Biology	5	5	560
4	Health Sciences	1	1	711
5	Natural Sciences	1	1	21

Shantanu Banerji

Publications

6.2K

Citations

H-Index

Page 1

	Year	Citations
Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing Marcin Imieliński, Alice H. Berger, Peter S. Hammerman, Cell Tumor BiologyEngineeringTumor HeterogeneityMedicineNext-generation Sequencing	2012	1.8K
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer Martin Peifer, Lynnette Fernandez‐Cuesta, Martin L. Sos, Nature Genetics EngineeringSomatic VariantTumor HeterogeneityMedicineGenetics	2012	1.4K
Sequence analysis of mutations and translocations across breast cancer subtypes Shantanu Banerji, Kristian Cibulskis, Claudia Rangel‐Escareño, Nature Recurrent MutationsBreast OncologyOncologyEngineeringSomatic Variant	2012	1.2K
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy Jordi Barretina, Barry S. Taylor, Shantanu Banerji, Nature Genetics Tumor HeterogeneityMedicinePathologyCancer GenomicsSubtype-specific Genomic Alterations	2010	711
Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of <i>ERBB2</i> Heidi Greulich, Bethany Kaplan, Philipp Mertins, Proceedings of the National Academy of Sciences Systems BiologySignal TransductionEngineeringTransformation AssaysSignaling Pathway	2012	264
Nuclear factor I/B is an oncogene in small cell lung cancer Alison L. Dooley, Monte M. Winslow, Derek Y. Chiang, Genes & Development OncologyOncogenic AgentMedicineMouse Sclc ModelNuclear Factor I/b	2011	174
Phase II study of PX-866 in recurrent glioblastoma Marshall Pitz, Elizabeth A. Eisenhauer, Mary MacNeil, Neuro-Oncology	2015	119
Molecular Pathways: PI3K Pathway Targets in Triple-Negative Breast Cancers Vallerie Gordon, Shantanu Banerji Clinical Cancer Research Her2 Receptor ExpressionOncologyEndocrine-related CancerBreast OncologyTherapeutic Breakthrough	2013	60
A Canadian Guideline on the Use of Next-Generation Sequencing in Oncology Stephen Yip, Anna Christofides, Shantanu Banerji, Current Oncology Ngs TechnologyGeneticsPathologyCancer RegistrationHigh Throughput Sequencing	2019	49
Canadian Consensus: Oligoprogressive, Pseudoprogressive, and Oligometastatic Non-Small-Cell Lung Cancer Scott A. Laurie, Shantanu Banerji, Normand Blais, Current Oncology	2019	45

Page 1